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Abstract Obesity has become a global epidemic, con-
tributing to the increasing burdens of cardiovascular dis-
ease and type 2 diabetes. However, the precise molecular
mechanisms of obesity remain poorly elucidated. The
hypothalamus plays a major part in regulating energy
homeostasis by integrating all kinds of nutritional signals.
This study investigated the hypothalamus protein proﬁle in
diet-induced obese (DIO) and diet-resistant (DR) rats using
two dimensional gel electrophoresis (2-DE) combined with
MALDI-TOF/TOF–MS analysis. Twenty-two proteins
were identiﬁed in the hypothalamus of DIO or DR rats.
These include metabolic enzymes, antioxidant proteins,
proteasome related proteins, and signaling proteins, some
of which are related to AMP-activated protein kinase
(AMPK) signaling or mitochondrial respiration. Among
these proteins, in comparison with the normal-diet group,
Ubiquitin was signiﬁcantly decreased in DR rats but not
changed in DIO rats, while Ubiquitin carboxyl-terminal
esterase L1 (UCHL-1) was decreased in DIO rats but not
changed in DR rats. The expression level of Ubiquitin and
UCHL-1 were further validated using Western blot analy-
sis. Our study reveals that Ubiquitin and UCHL-1 are
obesity-related factors in the hypothalamus that may play
an important role in the genesis of DR or DIO by inter-
fering with the integrated signaling network that control
energy balance and feeding.
Keywords Ubiquitin  UCHL-1  Diet- induced obesity 
Diet-resistant  Two-dimensional gel electrophoresis  Mass
spectrometry
Introduction
Obesity has become a global epidemic, contributing to the
increasing burdens of cardiovascular disease, type 2 dia-
betes, some types of cancer, and premature death [1, 2].
However, the molecular mechanism in pathogenesis of
obesity has not yet been fully elucidated. An increase in
food availability, in particular a high-energy diet, seems to
account for the development of obesity [3]. Interestingly, a
subset of the population appears to be sensitive to diet-
induced obesity (DIO), while others are diet-resistant (DR)
and can maintain a normal body weight even while on the
same diet as DIO individuals [4]. It has been reported that
some classic peptides are related to obesity, such as leptin,
ghrelin, and some hypothalamic neuropeptides [3, 5, 6]. In
our previous study, cocaine and amphetamine- regulated
transcript (CART), a-melanocyte stimulating hormone
(a-MSH) were up-regulated and recognized as anorexi-
genic neuropeptides to suppress the feeding behavior in DR
rats [7].
Recent research conﬁrms that, in the CNS, AMP-acti-
vated protein kinase (AMPK) responds to altered AMP/
ATP, nutrients, metabolites, and hormones related to body
energy status as well as in peripheral tissue. Hypothalamic
AMPK is located in energy-sensing neurons and circuits
for body energy homeostasis, and is thus positioned to
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ecules in AMPK signaling circuits all have important roles
in balancing energy intake and expenditure [9]. In addition,
many studies show that the Ubiquitin–proteasome system
(UPS) plays a crucial role in a wide variety of biological
processes, including the cell cycle, cell proliferation,
apoptosis and signal transduction [10, 11]. UPS is mainly
composed of Ubiquitin, Ubiquitin-activating enzyme,
Ubiquitin-conjugating enzymes, Ubiquitin ligases, protea-
somes, and deubiquitinating enzymes (Ubiquitincarboxyl-
terminal esterase L1, UCHL1). UCHL-1 appears to be
involved in regulating lipid synthesis in adipocyte as well
as lipid production by the liver, and could possibly regulate
the level of AMPK to inﬂuence the development of obesity
[10]. Interestingly, UCHL-1 has been found to be up-reg-
ulated in the cow hypothalamus in response to food
restriction [8]. Ubiquitin involved in the degradation of
AMPK by CIDEA (cell death-inducing DNA fragmenta-
tion factor-like effector A) gene in adipose tissue [12]. To
our knowledge, however, how or whether it is involved in
the central regulation of energy balance in DIO and DR rats
has never been investigated.
Quite a few previous studies have utilized proteomics to
study adipose tissue, pancreas and blood in obesity [13–
16]. However, no proteomics study on the hypothalamus
between DIO and DR rats have been reported. The hypo-
thalamus plays a major part in regulating energy homeo-
stasis by integrating all kinds of nutritional signals. In the
present study, two dimensional gel electrophoresis (2-DE)
was used in combination with mass spectrometry to search
for obesity related factors in the hypothalamus.
Experimental Procedures
Establishment of DIO and DR Model in Rats
Three-week-old male (45–55 g) Sprague–Dawley (SD) rats
were housed in at 22 ± 2C on a 12:12 h light/dark cycles
and fed with standard laboratory chow and water available
ad libitum during the ﬁrst week of the experiment. Animals
were randomly divided into two groups as previously
described [7]: (1) the control group (n = 15), fed with
standard laboratory chow (3.80 kcal/g); (2) the high-fat
diet (HIF) group (n = 60), fed with high-fat diet containing
4.76 kcal/g. After feeding for 14 weeks, rats in the HIF
diet-feeding group that exhibited higher body weights were
assigned to the DIO group; their individual body weights
surpassed the maximum individual body weights of rats in
the control group. Rats of the HIF diet group with lower
body weights were assigned to the DR group; their indi-
vidual body weights were no greater than the average
individual body weights of the control group rats.
Samples Preparation for 2-DE and Image Analysis
Under anesthetic with sodium pentobarbital, these rats
were sacriﬁced by decapitation. The brain was dissected
from the skull as previously described by Mantzoros CS: a
region bordered dorsally by the thalamus, rostrally by the
optic chiasm, and caudally by the mamillary bodies was
excised [17]. Hypothalamuses removed were immediately
frozen in liquid nitrogen. The 2-DE was performed with the
Amersham Pharmacia System. A total protein of 1 mg for
each sample was applied to an 18 cm length IPG dry strip
(pH 3-10 L). The IEF were performed on IPGphor3 IEF
system. The IPG strips were equilibrated ﬁrst for 30 min in
a buffer containing 50 mM Tris–HCl, 6.0 M urea, and
0.2% DTT, followed by 10% SDS–PAGE on a Protean
Plus Dodeca Cell (Bio-Rad, Hercules, USA) After 2-DE,
the gels were stained with coomassie brilliant blue R-350.
Images were digitized with an ImageScanner (GE Health-
care) and analyzed (spot detection, quantization, gel
matching) by using ImageMaster 2D platinum.
In-Gel Digestion and Protein Identiﬁcation by Mass
Spectrometry
Protein spots were excised from the gels for tryptic
digestion in-gel. The proteins were then incubated with
10 ll5 lg/ml trypsin overnight at 37C. The peptides
were extracted from the gel, mixed, vacuum-dried, and
stored for MS analysis. Matrix assisted laser desorption/
ionization time of ﬂight (MALDI-TOF) Tandem mass
spectrometry (MALDI-TOF-TOF–MS) were performed
using a 4700 Proteomics Analyzer (TOF/TOFTM)(Ap-
plied Biosystems, CA, USA). The MS data from both
MALDI-MS peptide ﬁngerprint mass spectra and tandem
mass spectra in the MS/MS experiments were searched
against a subset of rat proteins in the NCBInr protein
sequence database, using the Mascot v2.1 search program.
Search parameters used were: ‘‘trypsin’’ (enzyme),
‘‘carbamidomethyl (C)’’ (ﬁxed modiﬁcations), and ‘‘oxi-
dation (M)’’ (variable modiﬁcations).
Western Blot Analysis
Samplescontaining50 lgofproteinfromthe hypothalamus
of control, DIO, and DR rats were electrophoresed on a 12%
SDS polyacrylamide gel and transferred to a nitrocellulose
ﬁlter. The membranes were blocked in phosphate-buffered
saline for 2 h and then incubated overnight with an anti-
UCHL-1 rat polyclonal antibody, an anti-Ubiquitin rat
polyclonal antibody, or an anti-actin mouse monoclonal
antibody (Abcam, UK). The membranes were then incu-
bated for 1 h with HRP-conjugated secondary antibody.
SpeciﬁcproteinsweredetectedusinganECLkit(Amersham
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using Quantity One Software (Bio-Rad).
Statistics
Expression levels of the proteins were quantiﬁed by ana-
lyzing the intensity of each spot. Data were presented as
mean ± SE. Statistical differences between normal and
DIO groups and between normal and DR groups were
assessed through the one-way analysis of variance
(ANOVA), followed by Dunnett’s post-hoc test. P values
less than 0.05 (P\0.05) were considered to be statistically
signiﬁcant.
Results
Effect of HIF Diet on Body Weight and Energy
Consumption in DIO and DR Rats
Initial average body weight of the rats in the HIF diet group
(52.7 ± 0.6 g) did not differ signiﬁcantly from that of the
rats in the control group (52.2 ± 1.3 g) (P[0.05). At
14-weeks, the average body weight of rats in the HIF diet
group (including DIO and DR groups) was 631.2 ± 22.6 g,
which was 13.9% more than that of rats in the control
group (P\0.01). In the HIF diet group, the average body
weight of DIO rats was 688.9 ± 28.3 g, which was 29.6%
more than that of the DR rats (P\0.01). At 12–14 weeks,
a signiﬁcantly higher energy intake per day was observed
in DIO group (138.6 ± 12.9 kcal/day) as compared to the
DR group (112.3 ± 10.2 kcal/day) and the control group
(110.2 ± 13.0 kcal/day) (P\0.001) (Table 1).
Comparative Expressed Proﬁles of 2-DE Analysis
and Identiﬁed Proteins Differentially Expressed in DR
and DIO Groups
To detect proteins differently expressed in the hypothala-
mus, we investigated the hypothalamus protein proﬁle in
normal, DIO and DR rats by 2-DE. The 2-DE protein
patterns showed a resolution of approximately 1,280 ± 15,
1,250 ± 10, and 1,260 ± 12 protein spots in normal, DIO,
and DR groups, respectively. Protein spot positions and
intensities were compared between gel patterns of normal
and DIO groups and between that of normal and DR
groups. By comparing 2-DE gel proﬁles from normal and
DIO groups and from normal and DR groups, respectively
(Fig. 1), we identiﬁed 22 differentially expressed protein
spots in two groups by PMF or MS/MS analysis. Among
them are 7 up-regulated and 5 down-regulated proteins in
DR groups and 7 up-regulated and 7 down-regulated pro-
teins in DIO groups in comparison to the normal group,
respectively. Four down-regulated proteins are same in
both DIO and DR groups. These proteins are further cat-
egorized into 7 metabolic enzymes (spot 1,2,5,8,13,16,18
Table 2), 4 signaling proteins (spot 6, 7, 17, 20), 2 pro-
teasome related proteins (spot 10 and 12), 1 modulin of cell
cycle (spot 19), 1 antioxidant protein (spot 3), 1 speciﬁc
protein of neurocyte (spot 21), 3 proteins with other
functions (spot 4, 15 and 22), and 3 unknown proteins (spot
9, 11 and 14). Arrows in Fig. 1a, b, c indicated the variant
spots, which showed a signiﬁcant difference between two
gel patterns. Table 2 displays the identiﬁcation of proteins
differentially expressed in DIO or DR group in comparison
to normal group.
Differential Expressions of Ubiquitin Carboxyl-
Terminal Hydrolase L1 (UCHL-l), Ubiquitin in DIO
or DR Group Compared With Control Group
To probe the expression of UCHL-1 and Ubiquitin in
obesity, we cut out spot 10 and spot 12 (marked with
arrows) from the gel and verify their identities by MALDI-
TOF–MS or MS/MS. The trypsin peptide spectrums of spot
10 and spot 12 are shown in Figs. 2 and 3. Several peaks
were found in the theoretic sequence of UCHL-1 with a
score of 136, covering 72% of the whole protein, and in
that of Ubiquitin with a score of 167, covering 81% of the
whole protein.
To further characterize the changes in UCHL-1 and
Ubiquitin in DIO and DR groups, we quantiﬁed UCHL-1
and Ubiquitin levels using Western blotting. In agreement
with previous data from MS or MS/MS, the level of
UCHL-1 expression in the DIO group was signiﬁcantly
lower than that in the control (P\0.05). Similarly, the
level of Ubiquitin expression in the DR group was signif-
icantly lower than that in the control group (P\0.05)
(Fig. 4).
Discussion
Obesity, one of the most prevalent diseases in the world, is
associated with the consumption of a high-energy diet [18].
The task of identifying causative or contributory factors is
Table 1 Body weight and energy intake of rats in control, DR and
DIO groups (Mean ± SE)
Groups Numbers
of rats
Averaged body
weights (g)
Energy intake
(kcal/d)
Control 15 554.2 ± 20.2 110.2 ± 13.0
DR 15 531.4 ± 24.8 112.3 ± 10.2
DIO 30 688.9 ± 28.3*** 138.6 ± 12.9***
***P\0.001 compared with control group or DR group
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and the multiple metabolic perturbations that occur in
obese individuals. DIO and DR rat models have been used
in studying the role of nervous system in regulating feeding
behavior and energy homeostasis [19].
The hypothalamus has long been recognized as a major
site in the central nervous system to integrate a spectrum of
internal and external environmental information for energy
homeostasis [20]. In the present study, some identiﬁed
proteins are involved in energy metabolism, UPS, and
oxidative stress. Ubiquitin and UCHL-1 are both compo-
nents of UPS. Ubiquitin is recycled by proteolytic removal
from its conjugating protein by deubiquitinating enzymes
(DUBs). Our results showed that, compared to the normal
control group, Ubiquitin was down-regulated in the DR
group, though there was no signiﬁcant change in the DIO
group. Interestingly, one key member of deubiquitinating
enzymes, UCHL-1, was down-regulated only in the DIO
group, but not in the DR group. Ubiquitin carboxy terminal
hydrolase (UCH) is a subclass of DUBs that catalyzes the
hydrolysis of COOH-terminal ubiquityl esters and amides.
It removes Ubiquitin from ubiquitinated cellular proteins,
thereby preventing them from targeted degradation via the
proteasome pathway. In the DIO group, UCHL-1 with a
lower expression level could destroy the initial balance
between ubiquitin monomers and ubiquitin conjugates
[21]. The decrease of UCHL-1 in DIO rats may cause the
abnormal regulation of Ub system, as shown in Ubb
-/-
mice[22].The depletion of Ub from hypothalamic neurons
may interfere with the integrated signaling network that
controls energy balance and feeding in complex ways.The
obesity in DIO rats is likely the result of impaired function
of multiple hypothalamic networks such as melanocortin-3
receptor(Mc3r) signaling or AMPK signaling pathways
[23–25]. By contrast, we think the decrease of Ub in DR
rats might be associated with the normal facilitation of Ub
system. The hypothesis needs to be conﬁrmed further.
In the DR group, protein disulﬁde isomerase associated
3(PDIA3)(spot16) was also down-regulated in addition to
Ubiquitin. The protein disulphide-isomerase (PDI) family
encompasses several highly divergent proteins that are
involved in the processing and maturation of secretory
proteins in the endoplasmic reticulum (ER). Some studies
had demonstrated that PDI can interact with Ubiquitin,
Fig. 1 Proteome maps of the
hypothalamus of rats in normal
(a), DIO (b), and DR(c) groups.
Proteins were separated by
electrophoresis on IPG gels
(pI 3-10) and by SDS–PAGE,
stained with coomassie brilliant
blue R-350. Identiﬁed protein
spots are marked by arrows
with numbers
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123which has a ubiquitin-like domain and a ubiquitin-associ-
ated domain. Ubiquitin could serve as an adaptor protein
that both interacts with PDI and mediates the delivery of
poly-ubiquitylated proteins to the proteasome in the
vicinity of the ER membrane [26]. Down-regulation
of PDIA3 in the DR group might delay the hydrolysis of
Ubiquitin by proteasome and compensate the role of
ubiquitin-mediated AMPK degradation in DR rats. Kuhla’s
[8] research conﬁrmed that the UPS activated with up-
regulation of UCHL-1 in the hypothalamus of cows after
energy restriction. UCHL-1, a neuron speciﬁc peptidase,
could eliminate the misfolded or post-translationally
modiﬁed proteins by energy deprivation. Our results also
displayed abnormal activation of UPS in the hypothalamus
of rats fed with an HIF diet. These ﬁndings suggest that
UPS might play a role in the pathogenesis of DIO and DR.
The disruption of Ub pool dynamics could be a common
neuropathogenic mechanism in most late-stage neurode-
generatively diseases [22, 27]. However, the exact mech-
anism needs to be conﬁrmed further. In addition to, some
Table 2 Identiﬁcation of proteins differentially expressed in hypothalamus of DIO or DR in comparison to normal control group
Group Spot No* Spot ID MW pI Coverage % Fold change Protein name
DIO 1 gi|202837 39235 8.32423 36 1.62 Aldolase A
2 gi|8393502 25887 8.52664 32 2.31 Glutathione S-transferase,m1
3 gi|16923958 26011 8.26652 41 2.54 Peroxiredoxin 1
4 gi|75991707 18629 8.19503 52 1.87 Destrin
5 gi|8394009 17863 8.68517 50 1.72 Peptidylprolyl isomerase A
6 gi|6981010 15319 7.39654 33 2.06 Similar to zinc ﬁnger protein
7 gi|149060386 18652 7.08953 86 2.22 Fibroblast growth factor receptor 2
10 gi|61098212 24822 5.14365 72 0.38 Ubiquitin carboxyl-terminal hydrolase L1
16 gi|8393322 56526 5.80976 37 0.51 Protein disulﬁde isomerase associated 3
17 gi|984553 37369 5.39329 22 0.52 G protein beta 1 subunit
18 gi|85541051 33094 5.44817 48 0.44 Pyridoxal phosphate phosphatase
19 gi|13242243 38177 7.81951 12 0.45 Axin2
20 gi|149050967 15313 7.35061 31 0.48 E2F transcription factor 6
21 gi|4454311 14184 8.89452 32 0.49 Myelin basic protein
DR 8 gi|189011657 56418 8.45528 15 1.56 4-aminobutyrate aminotransferase
9 gi|55825 45637 6.28296 29 2.01 rCG25241, isoform CRA_b
11 gi|51948422 28155 9.01211 40 1.63 es1 protein
12 gi|51701919 8520 7.86224 81 0.42 Ubiquitin
13 gi|189011657 13550 9.302145 45 2.78 Ubiquinol-cytochrome c reductase binding protein
14 gi|54824 15982 9.02548 64 3.15 Unnamed protein product
15 gi|60678292 15275 8.45 37 2.44 Hemoglobin alpha 2 chain
16 gi|8393322 56526 5.80976 22 0.50 Protein disulﬁde isomerase associated 3
18 gi|85541051 33094 5.44817 48 0.48 Pyridoxal phosphate phosphatase
19 gi|13242243 38177 7.81951 12 0.49 Axin2
21 gi|4454311 14184 8.89452 32 0.51 Myelin basic protein
22 gi|157820637 18171 5.51243 17 2.05 Lymphatic vessel endothelial hyaluronan receptor 1
All the proteins were identiﬁed with a MALDI-TOF–MS or MS/MS, and the quality of match was evaluated at the signiﬁcant level (P\0.05)
for peptide ﬁngerprint mass spectra and/or peptide sequencing spectra
* The spot number is according to spot position in 2-DE. Spot ID is the accession number from NCBInr
MW molecular weight (Da), pI isoelectric point
Fig. 2 The panel shows enlarged spot 10 and spot 12 of the 2DE
protein proﬁle representing changes in control, DIO and DR groups
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123of differential expression proteins such as pyridoxal
phosphate phosphatase (spot18) related to AMPK signaling
by acetyl-CoA carboxylase(ACC), peroxiredoxin 1 (spot3)
and glutathione S-transferase, m1 (spot2) related to mito-
chondrial respiration with uncoupling protein 2(UCP2).
Whether these proteins act as food intake regulatory factors
linked to genesis of DIO and/or DR in hypothalamus
metabolism remains to be identiﬁed.
In summary, the proteomic analysis identiﬁes potential
new candidate molecules involved in maintaining energy
homeostasis in the hypothalamus of DIO or DR rats. Our
study reveals that Ubiquitin and UCHL-1 are obesity-
related factors in the hypothalamus and they may play an
important role in the genesis of DR or DIO by interfering
with the integrated signaling network that control energy
balance and feeding.
Fig. 3 The analysis of spot 10 and spot 12 using MALDI-TOF–MS. a Peptide mass ﬁngerprinting, b The peptide coverage maps (matched
peptides between spot 10 and UCHL-1, spot 12 and Ubiquitin)
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